European Wellness, Sinopharm, and NCL Solutions Embark on International Joint Venture!

We’re thrilled to announce that European Wellness have signed a binding Memorandum of Agreement (MoA) with biomedical tech giants Sinopharm Group and NCL Solutions on April 15, setting the stage for an exciting future of collaboration and growth between China and Malaysia!

This joint venture between EW Group, HK VJM Limited (representing Sinopharm Cloud Health Technology (Guangdong) Co., Ltd. and Sinopharm Traditional Chinese Medicine (Foshan) Medicine Co. Ltd.), and NCL Solutions Sdn. Bhd. marks a pivotal moment in international efforts to advance biomedicine and stem the tide of rising chronic illnesses globally. Crucially, we will be providing our expertise and experience in the research, development, formulation, and production of cell therapy solutions. In addition to collaborating on developing and equipping world-class health centers and venturing into co-branded products, over 1,000 SKUs of our proprietary products under EW Group will also be sold and distributed via Sinopharm’s extensive platform and distribution network.

With over 128,000 employees, 1,100 subsidiaries, 6 listed companies, and a full chain in the industry covering an array of departments including R&D, manufacturing, logistics, retail, events, healthcare services, and finances, Sinopharm is one of the largest healthcare groups in China. As established pharmaceutical experts, many of their production lines are approved by the US FDA and EU authorities and are prequalified by WHO – with the group earning substantial recognition during the coronavirus pandemic for their development and distribution of the Sinopharm vaccine, which proved to be instrumental in the fight against COVID-19.

There is no doubt that both industry giants stand to benefit from this joint partnership, with European Wellness providing our expertise on state-of-the-art biotechnology along with our proprietary world-class products and services, and Sinopharm leveraging their highly-acclaimed global reach and distribution network to help European Wellness achieve greater heights on the world stage. 🌎 We’re excited to work with Sinopharm and NCL Solutions to revolutionise the health and wellness industry and make excellent healthcare accessible to millions of people!

Prof. Dato’ Sri Dr. Mike Chan represented EW as its Founder and Chairman to sign the agreement – securing the incredible partnership that will help European Wellness achieve our goals and strive for innovation, growth, and excellence. During the signing ceremony, HK VJM Limited and NCL Solutions were represented Mr. Guo Liang and Ms. Cindy Chong Seau Joon respectively.